HCA - HCA Healthcare reports mixed Q4 earnings; initiates FY23 guidance

January, 27 2023 07:05 AM HCA Healthcare Inc.

HCA Healthcare press release ( NYSE: HCA ): Q4 GAAP EPS of $7.28 beats by $2.48 .
Revenue of $15.5B (+2.9% Y/Y) misses by $130M .
Adjusted EBITDA totaled $3.179B.
Cash flows from operating activities totaled $2.527B.
Same facility admissions increased 2.9% while same facility equivalent admissions increased 5.4%.
2023 Guidance: Revenues of $61.5 to $63.5 billion vs. consensus of $62.80B; EPS (diluted) of $16.40 to $17.60 per diluted share vs. consensus of $18.24; Adjusted EBITDA of $11.8 to $12.4 billion.
Capital expenditures for 2023, excluding acquisitions, are estimated to be approximately $4.3 billion.

For further details see: